Triglycerides, Remnant Cholesterol, and Inflammation in Schizophrenia
Author Information
Author(s): Wang Jeffrey, Kockx Maaike, Pennings Gabrielle J., Lambert Tim, Chow Vincent, Kritharides Leonard
Primary Institution: University of Sydney
Hypothesis
Are triglycerides and remnant cholesterol associated with systemic inflammation in patients with schizophrenia?
Conclusion
Triglycerides and remnant cholesterol levels do not correlate with systemic inflammation in patients with schizophrenia, suggesting they are independent contributors to cardiovascular risk.
Supporting Evidence
- Patients with schizophrenia had higher triglycerides and remnant cholesterol compared to controls.
- Systemic inflammation markers were elevated in patients with schizophrenia.
- Triglycerides and remnant cholesterol did not correlate with systemic inflammatory markers.
- IL-10 levels were increased in patients, suggesting an anti-inflammatory response.
- Findings indicate that triglycerides and remnant cholesterol may independently contribute to cardiovascular risk.
Takeaway
This study looked at people with schizophrenia and found that even though they had high levels of certain fats in their blood, these levels didn't match up with their inflammation levels, meaning they might be causing heart problems in different ways.
Methodology
The study measured fasting levels of triglycerides, cholesterol, and systemic inflammation markers in 147 patients with schizophrenia and 56 healthy controls.
Potential Biases
Potential bias due to the majority of patients being on clozapine, which may affect inflammation and lipid levels.
Limitations
The study did not include a naïve, untreated control group for comparison.
Participant Demographics
147 patients with schizophrenia on long-term antipsychotic treatment and 56 age- and sex-matched healthy controls.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website